logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Changfeng Pharmaceutical (02652.HK) spent 123,000 Hong Kong dollars on May 4 to repurchase 5,500 shares.

date
04/05/2026
Zhtng Cijng APP News, Changfeng Pharmaceutical (02652.HK) announced that on May 4, 2026, it spent 123,000 Hong Kong dollars to repurchase 5,500 shares.
Latest
4 m ago
L'Oreal signed a long-term licensing agreement with Adeia.
7 m ago
The digital company announced that it has obtained a $300 million senior secured transition financing credit facility, establishing a transition loan amount to be used for the construction of a third artificial intelligence data center.
8 m ago
Li Lai Canada Company has been approved by Health Canada to launch Kisunla.
8 m ago
Rei Canada's subsidiary Kisunla drug has been approved for listing by the Canadian Department of Health.
10 m ago
Strategy: As of May 3rd, holding 818,334 bitcoins with a total acquisition cost of $61.81 billion.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.